DexCom

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell DexCom and other ETFs, options, and stocks.

About DXCM

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE.

CEO

Kevin Ronald Sayer

CEOKevin Ronald Sayer

Employees

9,600

Employees9,600

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

1999

Founded1999

Employees

9,600

Employees9,600

DXCM Key Statistics

Market cap

33.71B

Market cap33.71B

Price-Earnings ratio

51.74

Price-Earnings ratio51.74

Dividend yield

—

Dividend yield—

Average volume

4.26M

Average volume4.26M

High today

$87.05

High today$87.05

Low today

$84.83

Low today$84.83

Open price

$86.23

Open price$86.23

Volume

4.06M

Volume4.06M

52 Week high

$142.00

52 Week high$142.00

52 Week low

$62.34

52 Week low$62.34

DXCM News

Seeking Alpha 6d

DexCom raised to outperform by Baird

Baird has upgraded DexCom (NASDAQ:DXCM) to outperform from neutral, citing increasing confidence in the company's ability to return revenue growth to the low-to...

TipRanks 6d

DexCom upgraded to Outperform from Neutral at Baird

Baird analyst Jeff Johnson upgraded DexCom (DXCM) to Outperform from Neutral with a price target of $104, up from $86. Since DexCom’s “surprising” Q4 shortfall,...

Analyst ratings

81%

of 26 ratings

Buy

80.8%

Hold

19.2%

Sell